TUFT1 and cancer: Immunohistochemistry (IHC) analyses showed that TUFT1 positivity rate was 63.0% (92/146) in the cancer tissue samples, which was significantly higher than that observed in the adjacent normal breast tissues (16.7%; 10/60 samples)(P= 0.000, Table 1).